Verastem (VSTM) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Verastem, Inc. (VSTM)
Last verastem, inc. earnings: 10/29 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
verastem.com
Company Research
Source: Yahoo! Finance
Image source: The Motley Fool. DATE March 4, 2026, 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Daniel Paterson Chief Commercial Officer — Michael Crowther Head of Development — Michael Glen Kauffman Chief Financial Officer — Daniel Calkins Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conference Call Transcript Daniel Paterson: Thank you, Julissa. Good afternoon, and thanks for joining our call today. 2025 was a truly transformative year for Verastem as we transition to a commercial stage company following our FDA approval of the first treatment specifically for KRAS-mutated recurrent low-grade serous ovarian cancer, nearly two months ahead of our PDUFA date. For the launch period of May through December 2025, we delivered $30.9 million of net product revenue and $17.5 million for the fourth quarter. I'm pleased to report that the strategies we put in place to guide our commercial launch continue to yield meaningful res
Show less
Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSTM alerts
High impacting Verastem, Inc. news events
Weekly update
A roundup of the hottest topics
VSTM
News
- Verastem (VSTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Verastem Inc (VSTM) Q4 2025 Earnings Call Highlights: Transition to Commercial Stage and ... [Yahoo! Finance]Yahoo! Finance
- Verastem Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Verastem outlines 2026 milestones with CO-PACK franchise set to be self-sustaining in H2 [Seeking Alpha]Seeking Alpha
VSTM
Earnings
- 3/4/26 - Beat
VSTM
Sec Filings
- 3/4/26 - Form 8-K
- 3/4/26 - Form 10-K
- 2/17/26 - Form SCHEDULE
- VSTM's page on the SEC website